CD8A and colorectal carcinoma: Researchers believe that CRC tumors with higher levels of intratumoral CD3+ and CD8+ T cell infiltration not only enhances antitumor immune responses [1345,1346,1347,1348], but also may experience greater responses to immunotherapy due to greater pre-existing immunogenicity [624].